Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

BATS BZX Real-Time Price
As of 1:42pm ET
 +1.05 / +1.72%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

3 Biotech Stocks to Buy in December
Dec 01 / MotleyFool.com - Paid Partner Content


1 month+7.74% 3 years+12.83%
3 months+1.42% 5 years+23.41%
1 year-14.79% Since inception+13.27%
Data through 12/02/2016

Quote Details

Previous close$61.14
Open day’s range60.62 – 62.65
Net asset value (NAV)61.19 (12/01/2016)
Daily volume762,887
Average volume (3 months)6,822,660
Data as of 1:42pm ET, 12/02/2016

Peer Comparisonvs. Health ETFs

Performance 5-yr return+23.41%+20.22%
Expense Gross exp ratio0.35%0.48%
Risk 5 year sharpe ratio0.781.04
Net assets$2.3B$1.0B
Average market cap$4.2B$31.6B
Average P/E--18.6
Dividend / Share--0.22%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
SRPT Sarepta Therapeutics Inc3.86%
INCY Incyte Corp2.94%
ALXN Alexion Pharmaceuticals Inc2.80%
UTHR United Therapeutics Corp2.68%
CELG Celgene2.62%
BIIB Biogen2.53%
GILD Gilead Sciences2.53%
REGN Regeneron Pharmaceuticals2.40%
IONS Ionis Pharmaceuticals Inc2.40%